Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
104.20    -0.60 (-0.57%)
Bid:
103.60
Ask:
105.40
Spread: 1.80 (1.737%)
Market Cap: £438.01m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Trading Update

15 Jun 2017 07:00

RNS Number : 1190I
PZ CUSSONS PLC
15 June 2017
 

15 June 2017

PZ Cussons Plc

(the "Group")

 

TRADING UPDATE

 

PZ Cussons Plc, a leading international consumer products group, today issues the following trading update in respect of the year ended 31 May 2017.

Overview

 

The board is pleased to announce that the overall performance of the Group has been in line with expectations.

 

The Group's balance sheet remains strong with cash generation for the period also in line with expectations.

 

Europe

 

In the UK, performance in the washing and bathing division has been robust with renovation and innovation continuing to drive good performance across Imperial Leather, Carex and Original Source despite competitive market conditions. The Imperial Leather range has been completely relaunched during the year and successful product launches have taken place under the Carex and Original Source brands.

 

In the beauty division, Sanctuary, St Tropez, Charles Worthington and Fudge have all performed well. The relaunch of the Sanctuary brand has now been completed with a new product range and a more premium look and feel. The new sub-brand, Being by Sanctuary, is now available in store and online and is targeting younger consumers with a range of 46 products. New product launches under the St Tropez brand include a new-to-market self-tan face mask.

 

Performance in the smaller markets of Poland and Greece has been in line with expectations.

 

Asia

 

In Australia, new product launches, range extensions and margin improvement initiatives have continued to improve the profitability of the business despite ongoing challenging trading conditions and all brands are performing well.

 

In Indonesia, good growth has continued across the brand portfolio with Cussons Baby strengthening its market leading position. Successful product launches in the year include the relaunch of the Cussons Kids range together with a new range of Imperial Leather products.

 

Performance in the smaller markets of Thailand and the Middle East has been in line with expectations.

 

Africa

 

In Nigeria, whilst liquidity has improved during the second half, availability of US dollars at the interbank rate remains low resulting in the need to continue accessing the secondary market.

 

All business units across Personal Care, Home Care, Electricals and Food & Nutrition have continued to trade relatively well in an environment where the consumer is under significant inflationary pressure. The Group's diverse product range with product offerings at all price points has ensured that market shares are held or grown across the brand portfolio.

 

Performance in the smaller markets of Ghana and Kenya has been in line with expectations.

 

Outlook

 

The strength and agility of the Group's brand portfolio is underpinning solid performance in all regions and new product launches are performing well.

 

Tight control of costs together with further margin improvement initiatives are successfully countering ongoing raw material and exchange rate volatility.

 

The Group's balance sheet remains strong and well placed to pursue new opportunities as they arise.

 

Final Results

 

Final results for the year ended 31 May 2017 will be announced on Tuesday 25 July 2017.

 

- ENDS -

For further information contact:

 

PZ Cussons Plc

Brandon Leigh - Chief Financial Officer

 

Tel: 0161 435 1236

Instinctif

Tim Linacre / Guy Scarborough

Tel: 020 7457 2020

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUQGQUPMGQC
Date   Source Headline
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding
9th Dec 20219:38 amRNSNotice of Interim Results
29th Nov 202111:25 amRNSDirector/PDMR Shareholding
25th Nov 20214:40 pmRNSDirector/PDMR Shareholding
23rd Nov 20214:05 pmRNSAnnual General Meeting
9th Nov 20217:00 amRNSDirector/PDMR Shareholding
15th Oct 20217:00 amRNSPublication of Annual Report and notice of AGM
24th Sep 20219:00 amRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading Statement
22nd Sep 20217:00 amRNSFinal Results
13th Sep 20213:00 pmRNSAppointment of Non Executive Director
27th Jul 202111:00 amRNSDirector/PDMR Shareholding
5th Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTrading update
29th Jun 202110:45 amRNSNotice of pre-close trading update
25th Jun 20217:00 amRNSAppointment of Non Executive Director
27th Apr 20217:00 amRNSTrading Statement
25th Mar 20217:00 amRNSCapital Markets Day
22nd Mar 20211:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20215:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20219:00 amRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSHalf-year Report
1st Dec 20203:45 pmRNSDirector/PDMR Shareholding
26th Nov 20202:30 pmRNSResult of AGM
26th Nov 20207:00 amRNSDirectorate Change
23rd Oct 202012:00 pmRNSPublication of Annual Report / Notice of AGM
20th Oct 20201:00 pmRNSHolding(s) in Company
1st Oct 20208:38 amRNSCompletion of Nutricima disposal
28th Sep 20203:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSTrading Statement
23rd Sep 20207:00 amRNSBoard Change
23rd Sep 20207:00 amRNSFinal Results for the year ended 31 May 2020
14th Aug 20208:50 amRNSDirector Declaration
6th Jul 20209:05 amRNSDirector Declaration
30th Jun 20205:30 pmRNSDirector/PDMR Shareholding
19th Jun 20209:29 amRNSDirector/PDMR Shareholding
5th Jun 20202:15 pmRNSRevised reporting timetable
28th May 20201:01 pmRNSDirector/PDMR Shareholding
22nd May 202010:20 amRNSDirector Declaration
28th Apr 202011:33 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSTrading Update for the Third Quarter 2020
14th Apr 20204:15 pmRNSBoard Change
2nd Apr 20207:00 amRNSUpdate on Settlement Agreement with Former CEO
19th Mar 20207:00 amRNSAppointment of new Chief Executive Officer
19th Mar 20207:00 amRNSBoard changes
18th Mar 20207:00 amRNSSale of Nutricima and completion of Luksja sale
20th Feb 20207:00 amRNSHolding(s) in Company
28th Jan 20207:00 amRNSHalf-year Report
12th Dec 20197:00 amRNSDirectorate Change
12th Dec 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.